Target intelligence / Profile preview

Complement system (also known as complement cascade) (Not a single molecule; represents a multi-protein cascade system)

Target
Not a single molecule; represents a multi-protein cascade system
Molecular classification
Multi-protein enzymatic cascade system, Individual components function as: Serine proteases, opsonins, anaphylatoxins, membrane-attack complex proteins, Approximately 50 plasma proteins and cell membrane receptors
01

Overview

The complement system is a multi-component cascade of approximately 50 proteins circulating in blood and tissue fluids that functions as a critical arm of innate immunity[1][6]. It can be activated through three distinct biochemical pathways—classical, alternative, and lectin—which converge on common effector mechanisms[1][7]. The system mediates three primary defense functions: direct pathogen lysis via membrane attack complex formation, enhanced phagocytosis through opsonization by C3b and its fragments, and recruitment of inflammatory cells through release of anaphylatoxins (C3a, C5a)[1][5]. Individual complement components serve as therapeutic targets for diseases characterized by either deficiency (leading to recurrent infections) or overactivation (causing tissue damage in conditions like atypical hemolytic uremic syndrome and C3 glomerulopathy)[1][3][4]. Therapeutic strategies have primarily focused on inhibiting the alternative pathway and specific complement components like C3 and C5, with development efforts aimed at achieving selective immune enhancement while avoiding excessive immunosuppression[1].

Other names
Complement cascadeHumoral innate immune systemComplement activationComplement fixation
02

Mechanism of action

Complement therapeutics operate through multiple proposed mechanisms: Pathway inhibition - Blocking classical, alternative, or lectin pathway activation. Component-specific inhibition - Targeting individual complement proteins (C3, C5, factor B, factor H) to prevent cascade amplification. Regulatory protein modulation - Enhancing or mimicking endogenous complement regulatory proteins (CD35, CD46, CD55, CD59). Terminal complex inhibition - Blocking membrane attack complex formation by preventing C9 polymerization.

03

Biological functions

Membrane attack/Cell lysis - Terminal complement components (C5b, C6, C7, C8, C9) form the membrane attack complex that creates pores in pathogen membranesOpsonization/Phagocytosis - C3b and its fragments coat pathogens, enhancing recognition and internalization by phagocytic cells through complement receptors (CR1, CR3, CR4)Inflammation and chemotaxis - C3a and C5a act as chemoattractants recruiting macrophages, neutrophils, and monocytes to infection sitesImmune complex clearance - Complement facilitates removal of immune complexes and apoptotic cellsMast cell degranulation - C3a, C4a, and C5a trigger mast cell activation independent of IgE, increasing vascular permeability and smooth muscle contractionAntibody response augmentation - Complement promotes and enhances antibody formation and immunologic memoryPathogen recognition and surveillance - Direct recognition of pathogens independent of antibody in early innate immunity
04

Disease associations

Infection/Sepsis - Complement deficiencies increase susceptibility to bacterial infections and sepsisInflammation-related disorders - Atypical hemolytic uremic syndrome and C3 glomerulopathy result from complement overactivation due to defective regulatory proteinsAutoimmune conditions - Inadequate immune complex clearance contributes to autoimmune disease pathologyHemolytic disease - Complement-mediated lysis causes Rh disease and immune hemolytic anemiaOther - Complement dysregulation implicated in development, differentiation, and local homeostasis
05

Safety considerations

Immunocompromise risk - Excessive complement inhibition may impair pathogen clearance and increase infection susceptibilityComplement-mediated tissue damage - Unregulated complement activation on host cells causes collateral tissue injury (hemolytic anemia, immune complex disease)Pathway redundancy - Multiple complement pathways provide functional redundancy, potentially limiting efficacy of single-pathway inhibitionLocation-dependent effects - Complement has dual possibilities (beneficial or harmful) depending on tissue location and local microenvironment
06

Interacting drugs

Therapeutic efforts focused on inhibition of the alternative pathway

1 more in the full profile.

Beyond the preview

Go deeper on Complement system (also known as complement cascade) (Not a single molecule; represents a multi-protein cascade system).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement system (also known as complement cascade) (Not a single molecule; represents a multi-protein cascade system).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call